Wall Street expects a year-over-year increase in earnings on lower revenues when American Well Corporation (AMWL) reports results for the quarter ended June 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on July 31, 2024, might help the stock move higher if these key numbers are better ...

Boston, July 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, will report its second quarter 2024 operating results on Wednesday, July 31. Following the distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The audio webcast can be accessed by visiting the Investors section of the company's website. Alter ...

Boston, June 28, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a small-cap growth healthcare company and a leading provider of healthcare software as a service, today announced that its Board of Directors (the "Board") has approved a 1-for-20 reverse stock split ("Reverse Split") of its Class A common stock, Class B common stock and Class C common stock (collectively, the "Common Stock"), that is expected to become effective on July 10, 2024 at 5:00 p.m. EDT. The shares of the Company's Class A common stock ...

Boston, June 28, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a small-cap growth healthcare company and a leading provider of healthcare software as a service, today announced that its Board of Directors (the “Board”) has approved a 1-for-20 reverse stock split (“Reverse Split”) of its Class A common stock, Class B common stock and Class C common stock (collectively, the “Common Stock”), that is expected to become effective on July 10, 2024 at 5:00 p.m. EDT. The shares of the Company’s Class A common stoc ...

Group 1 - Amwell appointed Ricky Goldwasser to its Board of Directors effective June 13, 2024, to enhance its focus on profitability and operational efficiency [1][2] - Goldwasser has a strong financial background with 15 years at Morgan Stanley and experience in leading successful IPOs, including Amwell's [2] - She replaces Deval Patrick, who served on the board since 2015 and contributed significantly to Amwell's telehealth initiatives [3] Group 2 - Amwell is a leading hybrid care delivery platform in the U.S. and globally, connecting providers, payers, patients, and innovators to improve healthcare access and quality [4] - The company supports over 50 health plans, representing more than 100 million covered lives, and aims to transform healthcare through hybrid care delivery [4]

Boston, June 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, today announces the appointment of Ricky Goldwasser to the company's Board of Directors, effective June 13. “Ricky brings to our board a deep financial background that makes her an invaluable addition as we focus on Amwell’s path to profitability. Ricky’s strong voice coupled with her impressive track record will help guide Amwell as we strive for greater efficiencies, optimized cash flow and profitable growt ...

Company Transition - Amwell co-founder Roy Schoenberg transitions from president and co-CEO to Executive Vice Chairman of the Board [1] - Ido Schoenberg assumes the role of sole Chief Executive Officer of Amwell [1] Leadership Impact - Roy Schoenberg has been instrumental in promoting digital healthcare since co-founding Amwell in 2006, advocating for the democratization of healthcare access through technology [2] - Under his leadership, Amwell's platform grew to over 100,000 active clinicians and millions of patients globally [2] Future Direction - The company is shifting focus from R&D investment to operational efficiency, cash flow optimization, and profitable growth [3] - Roy Schoenberg emphasizes the importance of leveraging new technology to achieve operational and clinical goals [3]

American Well Corporation (NYSE:AMWL) Q1 2024 Earnings Call Transcript May 1, 2024 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Robert Shepardson - Chief Financial Officer Conference Call Participants Charles Rhyee - TD Cowen Craig Hettenbach - Morgan Stanley Jessica Tassan - Piper Sandler Jailendra Singh - Truist Securities Matthew Shea - Needham & Company Stan Berenshteyn - Wells Fargo Securities Hanna Lee - Bank of America Jen ...

Core Insights - American Well Corporation (AMWL) reported a revenue of $59.52 million for the quarter ended March 2024, reflecting a 7% decline year-over-year [1] - The earnings per share (EPS) was -$0.25, slightly worse than the -$0.24 reported in the same quarter last year [1] - The revenue fell short of the Zacks Consensus Estimate of $61.1 million by 2.58%, while the EPS was also below the consensus estimate of -$0.18, resulting in a surprise of -38.89% [1] Revenue Breakdown - Platform subscription revenue was $24.86 million, slightly below the estimated $24.97 million, marking a year-over-year decrease of 13.4% [2] - Other revenue amounted to $3.59 million, which was lower than the average estimate of $3.93 million, but represented a significant year-over-year increase of 29.6% [2] - Revenue from visits was reported at $31.08 million, falling short of the estimated $33.28 million, and showing a 4.5% decline compared to the previous year [2] Stock Performance - Over the past month, shares of American Well have decreased by 32.7%, contrasting with a 4.1% decline in the Zacks S&P 500 composite [2] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [2]

American Well Corporation (AMWL) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.24 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -38.89%. A quarter ago, it was expected that this company would post a loss of $0.19 per share when it actually produced a loss of $0.17, delivering a surprise of 10.53%. Over the last four quarters, the company ...